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Long non-coding RNAs (lncRNAs) regulate diverse biological functions through mechanisms ascribed to the
lncRNA transcript itself. Now in Cell Stem Cell, Yin et al. (2015) use CRISPR/Cas9-mediated genome editing
to demonstrate discrete and opposing roles for the lncRNA Haunt transcript and DNA at the HOXA locus dur-
ing ESC differentiation.Long non-coding RNAs (lncRNAs) have
emerged as crucial players in regulating
gene expression through a variety of
mechanisms (Lee, 2012). lncRNAs are a
class of capped, polyadenylated RNAs
produced by Pol II that lack protein
coding potential, but are greater than
200 nucleotides in length (Ulitsky and Bar-
tel, 2013). Transcriptome analysis and
genome-wide RNAi screens have identi-
fied many functional lncRNAs involved
in embryonic stem cell (ESC) pluripo-
tency and differentiation; however, many
lncRNAs remain uncharacterized (Gutt-
man et al., 2011; Lin et al., 2014). Recent
studies have shown that lncRNAs func-
tion through a range of epigenetic,
transcriptional, and post-transcriptional
mechanisms such as chromatin modifica-
tion (Hotair and Tuna), X chromosome
inactivation (Xist), and splicing regulation
(Pnky) (Chu et al., 2011; Guttman et al.,
2011; Lee, 2012; Ramos et al., 2015;
Rinn et al., 2007), although much is still
unknown about mechanisms through
which lncRNAs act. While many of these
observations were based on traditional
RNAi-mediated knockdown and gene
overexpression, application of new tech-
nologies has yielded novel insights into
lncRNA function.
Now in Cell Stem Cell, Yin et al. (2015)
utilize the CRIPSR/Cas9 system to rigor-
ously dissect the function of the lncRNA
gene Haunt (HOXA upstream non-coding
transcript), using clever knockin and
knockout strategies (Yin et al., 2015). By
combining genome editing, RNAi deple-
tion, and overexpression techniques,
they demonstrate that the lncRNA Haunt
functions as a genetic enhancer and an
epigenetic repressor of HOXA gene acti-vation during retinoic acid (RA)-induced
ESC differentiation.
The authors first performed RNA-seq
analysis to identify lncRNAs critical for
ESC differentiation. They focused on
Haunt for further mechanistic studies
because it is highly expressed in ESCs
and neural lineages, although not in mes-
endodermal cells, and is in close prox-
imity to theHOXA cluster. Although Haunt
expression was downregulated during
differentiation induced by withdrawal of
LIF, depletion of Haunt by shRNA did not
significantly affect expression of self-
renewal genes or Hoxa1, suggesting that
Haunt is not critical for ESC self-renewal.
On the other hand, rapid activation of
Hauntwas observed preceding the induc-
tion of HOXA genes during RA-induced
differentiation, a well-established acti-
vator of HOX genes.
Yin et al. (2015) generated a series of
CRISPR-mediated genomic deletions at
the Haunt and HOXA loci by employing
the following knockout strategies: (1)
deletion of a region within the 2.3 kb
Haunt promoter; (2) deletion of a 7.3 kb
region covering the promoter and the
first two exons of Haunt; (3) deletion
of exon 3; and (4) deletion of the
entire Haunt locus and some flanking
genomic regions. Interestingly, strategy
(1) induced overexpression of HOXA
genes with RA treatment, consistent with
RNAi results, while the three other
Haunt knockout strategies displayed
attenuated HOXA expression under these
conditions. This discrepancy raised the
possibility that important regulatory ele-
ments required for HOXA activation may
reside in the large deleted genomic
regions.Cell Stem CeThe authors hypothesized that the
effect of deleting large segments of the
Haunt gene may modulate HOXA genes
by eliminating regulatory elements, inhib-
iting transcription, or reducing RNA tran-
script levels. To investigate the role of
Haunt lncRNA transcription in HOXA
expression, the authors introduced a
stop cassette immediately downstream
of the transcription start site (TSS) of
Haunt, thereby preventing its transcrip-
tion but retaining potential genetic regula-
tory elements contained in the Haunt
locus. This decreased Haunt transcription
but increased expression ofHOXA genes,
consistent with RNAi results and suggest-
ing that HOXA activation upon RA
treatment may be repressed by Haunt
RNA itself or the process of its transcrip-
tion. Additionally, insertion of a strong
constitutive promoter immediately up-
stream of the TSS of Haunt led to the
specific downregulation of many HOXA
genes, demonstrating that Haunt regu-
lates HOXA activation in cis. Such an
effect was not observed after trans-
poson-mediated trans overexpression,
again suggesting that the Haunt DNA
locus plays an important role in mediating
HOXA cluster expression.
The authors provided further evidence
to distinguish the function of Haunt RNA
transcripts from the DNA elements in the
Haunt locus. Deletion of a region encom-
passing the Haunt promoter to the end
of intron 2 resulted in downregulation of
HOXA genes, consistent with other Haunt
knockouts with larger deletions. Interest-
ingly, re-introducing Haunt cDNA after
deletion of the entire 57 kbHaunt genomic
locus likewise resulted in severe down-
regulation of HOXA genes rather than all 16, May 7, 2015 ª2015 Elsevier Inc. 449
Figure 1. The Two-Faced Mechanism of Haunt lncRNA, through Which It Fine-Tunes HOXA
Gene Expression
The regulatory elements embedded in the Haunt genomic region act as HOXA enhancers upon RA treat-
ment in ESCs, whereas Haunt RNA transcripts bind to HOXA loci and repress gene expression.
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additive effects on HOXA expression re-
sulting from loss of the Haunt lncRNA
in combination with the absence of
enhancer sequences after introduction
of the Haunt cDNA.
Enhancer sequences can interact with
the target gene locus through chromatin
looping (Montavon et al., 2011), and the
Haunt DNA locus contains several DNase
I hypersensitivity sites that are enriched
for epigenetic enhancer markers. The au-
thors performed chromatin conformation
capture (3C) and demonstrated that these
sites in the Haunt locus function as HOXA
enhancers, interacting with regions of the
HOXA loci via chromatin looping. They
next assessed whether these interactions
are inhibited by the Haunt lncRNA.
Chromatin isolation by RNA purification
(ChIRP) analysis confirmed that Haunt
RNAs specifically bind to HOXA genomic
loci; this association increased upon RA
treatment (Chu et al., 2011). Moreover,
there is an inverse association between
the enrichment of Haunt RNAs and the
expression levels of HOXA genes, indi-
cating a repressive role of Haunt tran-
scripts in HOXA induction. Although
lncRNAs such as Hotair have been known
to regulate the HOX family of genes
through PRC2-mediated chromatin modi-
fication (Rinn et al., 2007), the authors450 Cell Stem Cell 16, May 7, 2015 ª2015 Elhere propose a distinct regulatory mecha-
nism. In sum, their findings suggest a
model in which regulatory elements
embedded in the Haunt genomic region
act as HOXA enhancers upon RA treat-
ment of ESCs, whereas the Haunt RNA
transcript itself binds toHOXA loci and re-
presses gene expression (Figure 1).
Although the findings of Yin et al.
highlight the power and sensitivity of
CRISPR/Cas9 technology for convenient
and efficient gene editing, as the authors
emphasize, one must thoroughly examine
the genetic loci for regulatory elements
that may be unintentionally removed. In
a larger context, previous studies have
examined lncRNA genes and have identi-
fied RNAi-induced phenotypes that were
not revealed when the entire gene loci
was deleted (Schorderet and Duboule,
2011). In this case, the authors revealed
a regulatory role of Haunt lncRNA in the
control of HOXA genes through balancing
opposing genetic and epigenetic mecha-
nisms. They suggest that Haunt is regu-
lated by pluripotency factors such as
OCT4, NANOG, and SOX2 and that it con-
tains an RA response element upstream
of its promoter sequence. Intriguingly,
the authors point out that Haunt expres-
sion peaks at 12 hr after RA induction,
while HOXA genes peak between 1 and
3 days. If Haunt RNA acts as an inhibitorsevier Inc.of chromatin looping and thereby re-
presses HOXA, one would expect HOXA
expression to peak ahead ofHaunt. These
data may suggest additional regulatory
roles ofHaunt. This is one of several ques-
tions to be answered in future studies,
including what regulates Haunt’s role
as an enhancing or attenuating factor,
what role Haunt plays in physiological
conditions, and whether aberrant Haunt
expression results in an adverse pheno-
type. It would also be interesting to
know if this mechanism is conserved dur-
ing human ESC differentiation and how
many other lncRNAs may share a similar
multi-faceted regulatory mode. Rigorous
dissection of genomic segments using
CRISPR/Cas9 genomic editing, as illus-
trated in this work, may help to identify
cis and trans regulatory roles of DNA se-
quences and lncRNA transcripts.REFERENCES
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